The Valley Desk

NCT07455032 · Interventional trial

Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas

Overall registry status Recruiting

Phase 1

Conditions Squamous Cell Carcinoma of Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov